EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Noile-Immune Biotech's enterprise value is 円1,152.2 Mil.
Noile-Immune Biotech's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was 円305.5 Mil. Therefore, Noile-Immune Biotech's EV-to-Revenue for today is 3.77.
The historical rank and industry rank for Noile-Immune Biotech's EV-to-Revenue or its related term are showing as below:
TSE:4893'
s EV-to-Revenue Range Over the Past 10 Years
Min: 3.44 Med: 25.34 Max: 3539.85
Current: 3.77
During the past 4 years, the highest EV-to-Revenue of Noile-Immune Biotech was 3539.85. The lowest was 3.44. And the median was 25.34.
TSE:4893's EV-to-Revenue is ranked better than 68.79% of 1038
companies
in the Biotechnology industry
Industry Median: 7.97
vs TSE:4893: 3.77
Noile-Immune Biotech EV-to-Revenue Historical Data
The historical data trend for Noile-Immune Biotech's EV-to-Revenue can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Noile-Immune Biotech's EV-to-Revenue
For the Biotechnology subindustry, Noile-Immune Biotech's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Noile-Immune Biotech's EV-to-Revenue Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Noile-Immune Biotech's EV-to-Revenue distribution charts can be found below:
* The bar in red indicates where Noile-Immune Biotech's EV-to-Revenue falls into.
Noile-Immune Biotech's current Enterprise Value is 円1,152.2 Mil.
Noile-Immune Biotech's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was 円305.5 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Noile-Immune Biotech's share price for today is 円150.00.
Noile-Immune Biotech's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was 円7.06.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Noile-Immune Biotech EV-to-Revenue Related Terms
Thank you for viewing the detailed overview of Noile-Immune Biotech's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.
Noile-Immune Biotech (TSE:4893) Business Description
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
TSE:4893 has been successfully added to your